The Full Wiki

More info on 6,7-Methylenedioxy-2-aminotetralin

6,7-Methylenedioxy-2-aminotetralin: Wikis

Advertisements
  
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

6,7-Methylenedioxy-2-aminotetralin
Systematic (IUPAC) name
5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-7-amine
Identifiers
CAS number  ?
ATC code  ?
PubChem 36483
Chemical data
Formula C 11H13NO2  
Mol. mass 191.223 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status Uncontrolled
Routes  ?

6,7-Methylenedioxy-2-aminotetralin (MDAT) is a psychoactive drug and research chemical developed in the 1990s by a team at Purdue University led by David E. Nichols.[1] It appears to act as a serotonin releasing agent (SRA) based on rodent drug discrimination assays comparing it to MDMA ("Ecstasy"), in which it fully substitutes for, and lacks any kind of serotonergic neurotoxicity.[1] Hence, MDAT is a non-neurotoxic, putative entactogen in humans. It is closely related to and associated with its rigid indane analogues MDAI, MDMAI, and MMAI.

See Also

References

  1. ^ a b Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM (February 1990). "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry 33 (2): 703–10. PMID 1967651.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message